Precision Controlled Release of Biologics

Enable long-acting controlled release for peptides and other biologics by precision encapsulation. Control particle size, morphology, composition and more using IN-AIR-MICROFLUIDICS™ technology.

Discuss your project Explore our technology

A single platform delivering precision, performance, and scale

We turn complex formulation challenges into high-quality, scalable microparticle solutions.

Preserve biological activity

Formulation and process development focused on maintaining the integrity and activity of sensitive peptides and proteins

Engineer controlled release

Tuned particle size, morphology and internal structure to balance drug loading, initial burst and release duration.

Enable scalable production

Connect early formulation development with scalable production through parallel operation of our IN-AIR MICROFLUIDICS™ nozzles.

Particle morphology is key for controlled release

Release performance depends on more than just particle size. The distribution of your biologic within a particle and the structure surrounding it determine how it is protected and released.

With our IN-AIR MICROFLUIDICS™ technology we have control over particle size, composition and morphology. Using sold and porous matrix particles to core-shell structures, we address your formulation’s biologics loading, initial burst and release duration targets.

Precision engineering for scalable production

Our expertise in nozzle design and process engineering enables precise control over particle size, uniformity and internal structure. Parallel nozzle operation increases throughput while maintaining consistent conditions at each nozzle and uniform particle production.

We integrate early formulation development with the practical requirements of production at scale, including process stability, reproducibility and efficient use of valuable materials.

superior microencapsulation

One encapsulation platform. Endless possibilities.

IN-AIR MICROFLUIDICS™ offers microfluidic-level precision at industry-relevant scales. Our platform translates complex formulation challenges into microparticles with consistent quality and performance.

With proprietary encapsulation technology and strong formulation capabilities, we support products from early development to manufacturing, through microencapsulation services, co-development, or equipment integration.

We focus on microparticles designed to go in and on the body, including controlled injectables, scalable cell therapies, 3D cell culture solutions, and oral or topical delivery of protected bioactives.

Our process is built for seamless scaling from lab to operations and supports go-to-market via in-house small commercial batch production under an ISO 9001 quality management system.

Learn more